After months of international availability, the Dexcom G7 constant glucose monitor received its FDA clearance to distribute in the US. Ahead of the wide rollout, we got to go hands-on with a demo ...
Morning Overview on MSN
A single-patch sensor now reads blood sugar through the skin with no needle stick — and the first versions are already on their way to pharmacy shelves
For decades, checking blood sugar meant the same routine: a lancet, a test strip, a drop of blood, and a number that told you ...
We’ve come a long way in continuous glucose monitoring (CGM) technology since it first hit the market over two decades ago, and San Diego-based Dexcom has been leading the way on innovation for most ...
LONDON--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results